Most recent headlines around neurodegenerative disease research are in the context of a multi-billion-dollar drug failure. But whilst there have been some (extremely expensive) setbacks for long-standing theories in the field, novel research directions have recently emerged that offer routes towards an effective therapy. These findings suggest that we might need to look at novel cells, brain areas, and even new areas of the body in order to understand and fight these complex conditions.

“Let me just start out by saying that epidemiological studies have shown for some time that for two age-related neurodegenerative diseases, Alzheimer’s and Parkinson’s, there seems to be a window of time during which anti-inflammatory drugs may have reduced the incidence of Alzheimer’s and Parkinson’s later in life if they were consumed chronically,” says Malu Tansey, a Professor and Directo of the Center for Translation Research in Neurodegenerative Disease at the University of Florida.

View Full Article

You need to login or register to bookmark/favorite this content.